Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 7/20 | 0.44 |
| ▸ | GRPR | P30550 | 2/20 | 0.43 |
| ▸ | REN | P00797 | 7/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15444513 | 0.95 | CTSD (0.45) | CTSDGRPRREN | |
| SCHEMBL12767762 | 0.93 | REN (0.46) | CTSDGRPRRENBACE1BACE2 | |
| SCHEMBL15444508 | 0.92 | CTSD (0.44) | CTSDGRPRREN | |
| SCHEMBL30641648 | 0.91 | REN (0.43) | CTSDGRPRREN | |
| SCHEMBL12767663 | 0.88 | REN (0.47) | CTSDREN | |
| SCHEMBL29473455 | 0.84 | GRPR (0.57) | GRPRREN | |
| SCHEMBL29556991 | 0.84 | REN (0.46) | CTSDREN | |
| SCHEMBL15444494 | 0.84 | REN (0.53) | CTSDREN | |
| SCHEMBL16716014 | 0.84 | GRPR (0.57) | GRPRREN | |
| SCHEMBL1404309 | 0.83 | GRPR (0.47) | GRPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4618991-A1 | PHARMACEUTICAL COMBINATIONS AND USES THEREOF | Novartis AG (CH) | 2025-09-24 | — | — | EP | disclosed |
| EP-4387944-A1 | RADIOPHARMACEUTICALS, METHODS FOR THE PRODUCTION THEREOF, AND USES IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES | Clarity Pharmaceuticals Ltd (AU) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024105610-A1 | PHARMACEUTICAL COMBINATIONS AND USES THEREOF | NOVARTIS AG (CH) | 2024-05-23 | — | — | WO | disclosed |
| EP-4188457-A1 | CONJUGATE OR ITS SALT COMPRISING A GASTRIN-RELEASING PEPTIDE RECEPTOR ANTAGONIST AND USES THEREOF | Orano Med (FR) | 2023-06-07 | — | — | EP | disclosed |
| WO-2023019303-A1 | RADIOPHARMACEUTICALS, METHODS FOR THE PRODUCTION THEREOF, AND USES IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES | Clarity Pharmaceuticals Ltd (AU) | 2023-02-23 | — | — | WO | disclosed |
| WO-2022063850-A1 | CONJUGATE OR ITS SALT COMPRISING A GASTRIN-RELEASING PEPTIDE RECEPTOR ANTAGONIST AND USES THEREOF | ORANO MED (FR) | 2022-03-31 | — | — | WO | disclosed |